About PT-141 (Bremelanotide)
PT-141, also known as Bremelanotide, is a synthetic peptide derived as a metabolite/analog of Melanotan II. Like its parent compound, PT-141 acts as a melanocortin receptor agonist — but research has focused on its activity at the MC4R subtype in particular, which is concentrated in the hypothalamus and other regions of the central nervous system.
The key distinction researchers draw between PT-141 and PDE5 inhibitors (such as sildenafil-class compounds) is mechanism of action: PDE5 inhibitors work peripherally, enhancing blood flow through the nitric oxide pathway. PT-141, by contrast, is studied as acting centrally — its effects on sexual arousal and desire are examined as occurring independently of the nitric oxide / vascular pathway. Because this central mechanism is not specific to male physiology, PT-141 has been studied for its influence on arousal and desire in both male and female research models.
Research Applications
PT-141 is used in research investigating melanocortin receptor pharmacology (particularly MC4R), central nervous system pathways involved in sexual arousal and desire, and comparative studies against peripherally-acting compounds such as PDE5 inhibitors. Its receptor-selective profile relative to Melanotan II also makes it a reference compound in melanocortin agonist research.